维普中文期刊产品整合服务
73篇 您的检索式:作者名="Thrailkill"
    题名 作者 年代 出处 被引量
1Matrix metallopro- teinase-2 dysregulation in type 1 diabetes显示文摘Thrailkill K M Bunn R C Moreau C S 2007Diabetes Care2007,30,9:1
2Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues显示文摘Thrailkill KM Lumpkin CK Jr Bunn RC 2005Am J Physiol Endocrinol Metab2005,289,5:1
3Determinants of undercarboxylated and carboxylated osteocalcin concen- trations in type 1 diabetes显示文摘Thrailkill KM Jo CH Cockrell GE 2012Osteoporos Int2012,23,6:1
4Matrix metalloproteinases: Their potential role in the pathogenesis of diabetic nephropathy 显示文摘Thrailkill KM Clay Bunn R Fowlkes JL 2009Endocrine2009,35,1:1
5Matrix metalloproteinas-es:their potential role in the pathogenesis of diabetic nephropathy显示文摘Thrailkill KM Clay Bunn R Fowlkes JL 2009Endocrine2009,35,1:1
6Effects of systemic and local administration of recombinant human IGF- I( rhlGF- I) on de novo bone formation in an aged mouse model 显示文摘Fowlkes JL Thrailkill KM Liu L 2006J Bone Miner Res2006,21,9:1
7Flow Parame- ters in a Shallow Conduit-flow Carbonate Aquifer, Inner Bluegrass Karst Region, Kentucky, USA 显示文摘Thrailkill J Sullivan S B Gouzie D R 1991Journal of Hydrology1991,129,14:1
8Matrix metalloproteinase - 2 dysregulation in type 1 diabetes 显示文摘Thrailkill KM Bunn RC Moreau CS 2007Diabetes Care2007,30,9:1
9Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytie mul- tiligand receptors megalin and cubilin 显示文摘Thrailkill KM Nimmo T Bunn RC 2009Diabetes Care2009,32,7:1
10Determinants of undercar- buxylatcd and earboxylated osteocalcin concentrations in type 1 dia- betes 显示文摘Thrailkill KM Jo CH Cockrell GE 2012Osteoporos Int2012,23,6:1
11Matrix metalloproteinase-2 dysregulation in type 1 diabetes显示文摘Thrailkill KM Bunn RC Moreau CS 2007Diabetes care2007,30,9:1
12Efficacy and safety of mecasermin rinfabate显示文摘KEMP SF FOWLKES JL THRAILKILL KM 2006Exp Opin Biol Ther2006,6,5:1
13Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy 显示文摘Thrailkill KM Clay Bunn R Fowlkes JL 2009Endocrine2009,35,1:1
14Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues显示文摘 Lumpkin CK Jr Bunn RC 2005Am J Physiol Endocrinol Metab2005,289,5:1
15Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on denovo bone formation in an aged mouse model显示文摘Fowlkes JL Thrailkill KM Liu L 2006Bone Miner Res2006,21,9:1
16Disease andgender-specific dysregulation of NGAL and MMP-9 in type 1diabetes mellitus显示文摘Thrailkill KM Moreau CS Cockrell GE 2010Endocrine2010,37,2:1
17The Scarlet Letter Romantic Medicine显示文摘Thrailkill J F 2006Studies in American Fiction2006,34,1:1
18Matrix metalloproteinase - 2 dysregulation in type 1 diabetes显示文摘Thrailkill KM Bunn RC Moreau CS 2007Diabetes Care2007,30,9:1
19Matrix metallopro- teinases:their potential role in the pathogenesis of diabetic nephropathy 显示文摘Thrailkill KM Clay Bunn R Fowlkes JL 2009Endocrine2009,35,1:1
20Matrix metallo- proteinases : their potential role in the pathogenesis of dia betic nephropathy显示文摘Thrailkill KM Clay Bunn R Fowlkes JL 2009Endocrine2009,35,1:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费